Immunic | VTL - Operating Expenses


Immunic reported $23.33M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
BioMarin Pharmaceutical USD 636.56M 39.61M Mar/2026
Cipla INR 59.27B 1.71B Mar/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.29M 1.51M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Enanta Pharmaceuticals USD 126.59M 346.51M Dec/2025
Grifols EUR 1.99B 217.4M Dec/2025
Immunic USD 23.33M 2.67M Dec/2025
Insmed USD 506.24M 7.31M Mar/2026
Omeros USD 59.16M 20.13M Jun/2024
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 1.85B 1.09B Mar/2026
Ultragenyx Pharmaceutical USD 305M 16M Mar/2026
United Therapeutics USD 5.9B 5.1B Mar/2026
Xoma USD 22.84M 1.67M Sep/2024